RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder
Part of paid clinical trials in Reno, Nevada.
- Sponsor
- Vensica Therapeutics Ltd.
- Study ID
- NCT07553065
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Overactive Bladder (OAB)
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- NT 201 200U and Vibe System — COMBINATION_PRODUCTCombination of NT 201 200U and the ultrasound based system (Vibe System) for intravesical administration of the drug in a minimally invasive procedure
- NT 201 300U and Vibe System — COMBINATION_PRODUCTCombination of NT 201 300U and the ultrasound based system (Vibe System) for intravesical administration of the drug in a minimally invasive procedure
- Placebo and sham — COMBINATION_PRODUCTPlacebo identical in package and appearance to NT 201 together with all steps of Vibe System preparation and insertion to the bladder, but without the actual activation of the ultrasound energy
Study Details
This Phase 2b study is a prospective, multicenter, double blind, randomized, placebo and sham controlled trial to assess the safety, efficacy and dose response of NT 201 delivered by the Vibe System in participants with idiopathic overactive bladder (OAB).
Key Dates
- First listed
- Apr 27, 2026
- Start date
- Aug 14, 2026
- Status verified
- Aug 2026
- Primary completion
- Sep 30, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 210 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Active arm: NT 201 200U and Vibe System
- Active Comparator: Active arm: NT 201 300U and Vibe System
- Placebo Comparator: Control arm: Placebo (drug-free solution) and sham (i.e., insertion of the Vibe Catheter with no act
Primary Outcome Measure
Mean daily urinary incontinence [ Time Frame: 12 weeks ]
Central Contacts
- Tami Abudi972525989833
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Urology Nevada | Reno | Nevada | 89511 | Tami Abudi |
Find similar trials in Reno, NV
By research site
Related Studies
- Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in WomenRecruiting · InMode MD Ltd. · Palo Alto, California
- PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OABRecruiting · Axonics, Inc. · Chicago, Illinois
- APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in WomenRecruiting · Medstar Health Research Institute · Birmingham, Alabama
- Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder FunctionRecruiting · Northwestern University · Chicago, Illinois